Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Taking the STING out of TLR-driven autoimmune diseases: good, bad, or indifferent?
AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer.
Joseph, Jillian
Using circulating cell-free DNA to monitor personalized cancer therapy.
The data must be accessible to all.
See All 10 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The data must be accessible to all.
Gierasch LM, Davidson NO, Rye KA, Burlingame AL. The data must be accessible to all. J Lipid Res. 2020 04; 61(4):465.
View in:
PubMed
subject areas
Communication
Policy
Publications
Research Design
Science
authors with profiles
Lila M Gierasch Ph.D.